Celadon Pharmaceuticals

Pre-clinical

London, United KingdomFounded 2018celadonpharma.com

Develops cannabis-based medicines for neurological and rare diseases.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $10.5M

Develops cannabis-based medicines for neurological and rare diseases.

NeuroscienceRare Disease

Total raised:$10.5M

IPO$10.5MUndisclosedMay 17, 2022